Mokobio Biotechnology R&D Center serves as the Research & Development pioneer of the Mokobio Life Science Group. Its main business is independent research and innovation of in-vitro diagnostic (IVD) technology. It has formed three segments including gene platform diagnostic reagents and related testing services, immune platform diagnostic reagents, and testing equipment. At Mokobio, our scientist team focus on developing the next-generation platform that enables reliable IVD tests to promote the health of public across the world. We specialize in developing molecular diagnostic assay in the field of Point of Care Test (POCT) and precision medicine. With integrity, respect, efficiency, and integration, we are making a difference and creating a better world.